| Recruitment status | No longer recruiting |
| Unique ID issued by UMIN | UMIN000030704 |
| Receipt No. | R000035055 |
| Scientific Title | Monitoring of influenza vaccine effectiveness among Japanese children (2017/18 - 2019/20 season) |
| Date of disclosure of the study information | 2018/01/09 |
| Last modified on | 2021/05/06 (Ver. 10) |
| Basic information | ||
| Public title | Monitoring of influenza vaccine effectiveness among Japanese children (2017/18 - 2019/20 season) | |
| Acronym | Monitoring of influenza vaccine effectiveness among Japanese children (2017/18 - 2019/20 season) | |
| Scientific Title | Monitoring of influenza vaccine effectiveness among Japanese children (2017/18 - 2019/20 season) | |
| Scientific Title:Acronym | Monitoring of influenza vaccine effectiveness among Japanese children (2017/18 - 2019/20 season) | |
| Region |
|
|
| Condition | |||
| Condition | Influenza | ||
| Classification by specialty |
|
||
| Classification by malignancy | Others | ||
| Genomic information | NO | ||
| Objectives | |
| Narrative objectives1 | We aim to monitor influenza vaccine effectiveness among Japanese children. |
| Basic objectives2 | Efficacy |
| Basic objectives -Others | |
| Trial characteristics_1 | |
| Trial characteristics_2 | |
| Developmental phase | |
| Assessment | |
| Primary outcomes | Laboratory-confirmed influenza |
| Key secondary outcomes | |
| Base | |
| Study type | Observational |
| Study design | |
| Basic design | |
| Randomization | |
| Randomization unit | |
| Blinding | |
| Control | |
| Stratification | |
| Dynamic allocation | |
| Institution consideration | |
| Blocking | |
| Concealment | |
| Intervention | |
| No. of arms | |
| Purpose of intervention | |
| Type of intervention | |
| Interventions/Control_1 | |
| Interventions/Control_2 | |
| Interventions/Control_3 | |
| Interventions/Control_4 | |
| Interventions/Control_5 | |
| Interventions/Control_6 | |
| Interventions/Control_7 | |
| Interventions/Control_8 | |
| Interventions/Control_9 | |
| Interventions/Control_10 | |
| Eligibility | ||||
| Age-lower limit |
|
|||
| Age-upper limit |
|
|||
| Gender | Male and Female | |||
| Key inclusion criteria | 1) Children with influenza-like illness (ILI) who visited collaborating pediatric clinics in Osaka/Fukuoka prefecture, Japan, during the 2017/18, 2018/19 and 2019/20 influenza season
2) Aged less than 6 years at the time of visit 3) Those who visited the clinics between 6 hours and 7 days after onset of fever (38.0 degree) |
|||
| Key exclusion criteria | Subjects are excluded if they:
- are aged less than 6 months, as of the last September 1st before each season - have a history of anaphylaxis after influenza vaccination - had influenza antivirals administered for the current ILI - experienced the current ILI during the hospitalization - are institutionalized - are non-residents in Osaka/Fukuoka prefecture, Japan |
|||
| Target sample size | 3600 | |||
| Research contact person | |||||||
| Name of lead principal investigator |
|
||||||
| Organization | Osaka City University Graduate School of Medicine | ||||||
| Division name | Department of Public Health | ||||||
| Zip code | 545-8585 | ||||||
| Address | 1-4-3, Asahi-machi, Abeno-ku, Osaka 545-8585, Japan | ||||||
| TEL | 06-6645-3756 | ||||||
| wakaba@med.osaka-cu.ac.jp | |||||||
| Public contact | |||||||
| Name of contact person |
|
||||||
| Organization | Osaka City University Graduate School of Medicine | ||||||
| Division name | Department of Public Health | ||||||
| Zip code | 545-8585 | ||||||
| Address | 1-4-3, Asahi-machi, Abeno-ku, Osaka 545-8585, Japan | ||||||
| TEL | 06-6645-3756 | ||||||
| Homepage URL | |||||||
| wakaba@med.osaka-cu.ac.jp | |||||||
| Sponsor | |
| Institute | Osaka City University |
| Institute | |
| Department | |
| Funding Source | |
| Organization | Ministry of Health, Labour and Welfare, Japan |
| Organization | |
| Division | |
| Category of Funding Organization | Japanese Governmental office |
| Nationality of Funding Organization | Japan |
| Other related organizations | |
| Co-sponsor | |
| Name of secondary funder(s) | |
| IRB Contact (For public release) | |
| Organization | Osaka City University Graduate School of Medicine Institutional Review Board |
| Address | 1-5-7, Asahi-machi, Abeno-ku, Osaka 545-8585, Japan |
| Tel | 06-6645-3457 |
| ethics@med.osaka-cu.ac.jp | |
| Secondary IDs | |
| Secondary IDs | NO |
| Study ID_1 | |
| Org. issuing International ID_1 | |
| Study ID_2 | |
| Org. issuing International ID_2 | |
| IND to MHLW | |
| Institutions | |
| Institutions | 大阪市立大学大学院医学研究科公衆衛生学、大阪健康安全基盤研究所、ふじおか小児科(大阪府)、松下こどもクリニック(大阪府)、くぼたこどもクリニック(大阪府)、八木小児科(大阪府)、高崎小児科医院(福岡県)、しんどう小児科医院(福岡県)、やました小児科医院(福岡県)、横山小児科医院(福岡県)、きよまつ小児科医院(福岡県) |
| Other administrative information | |||||||
| Date of disclosure of the study information |
|
||||||
| Related information | |
| URL releasing protocol | https://mhlw-grants.niph.go.jp/system/files/2018/182111/201818022A_upload/201818022A0009.pdf |
| Publication of results | Partially published |
| Result | |||||||
| URL related to results and publications | https://mhlw-grants.niph.go.jp/system/files/2018/182111/201818022A_upload/201818022A0009.pdf | ||||||
| Number of participants that the trial has enrolled | 2054 | ||||||
| Results | Vaccine effectiveness of 2 doses
2017-18 season (under 6 years of age): 63% 2018-19 season (under 3 years of age): 42% 2019-20 season (under 3 years of age): 62% |
||||||
| Results date posted |
|
||||||
| Results Delayed | |||||||
| Results Delay Reason | |||||||
| Date of the first journal publication of results | |||||||
| Baseline Characteristics | 2017-18 season: 1,015 children aged less than 6 years (boys: 561, girls: 454, mean age: 2.8 years)
2018-19 season: 397 children aged less than 3 years (boys: 216, girls: 181, mean age: 1.3 years) 2019-20 season: 642 children aged less than 3 years (boys: 334, girls: 308, mean age: 1.4 years) |
||||||
| Participant flow | Prospective, active and systematic recruitment from children aged less than 6 years (2017-18 season) or less than 3 years (2018-19 season and 2019-20 season) who visited collaborating pediatric clinics due to influenza-like illness during influenza season | ||||||
| Adverse events | None | ||||||
| Outcome measures | Influenza vaccine effectiveness against laboratory-confirmed influenza based on real-time RT-PCR | ||||||
| Plan to share IPD | |||||||
| IPD sharing Plan description | |||||||
| Progress | |||||||
| Recruitment status | No longer recruiting | ||||||
| Date of protocol fixation |
|
||||||
| Date of IRB |
|
||||||
| Anticipated trial start date |
|
||||||
| Last follow-up date |
|
||||||
| Date of closure to data entry | |||||||
| Date trial data considered complete | |||||||
| Date analysis concluded | |||||||
| Other | |
| Other related information | 1) Study design: case-control study (test-negative design)
2) Cases and controls: cases are subjects with positive results for influenza tested by real-time reverse transcription polymerase chain reaction using nasal aspirates, whereas controls are subjects with negative results 3) Exposure: history of influenza vaccination during the each season |
| Management information | |||||||
| Registered date |
|
||||||
| Last modified on |
|
||||||
| Link to view the page | |
| URL(English) | https://upload.umin.ac.jp/cgi-open-bin/icdr_e/ctr_view.cgi?recptno=R000035055 |